Glaucia Carielo Lima
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Glaucia Carielo Lima has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Emilly Santos Oliveira
Faculty of Nutrition, Federal University of Goias, Goiânia 74605-080, Brazil
4 shared publications - Flávia Campos Corgosinho
Faculty of Nutrition, Federal University of Goias, Goiânia 74605-080, Brazil
4 shared publications - Fabiana Martins Kattah
Faculty of Nutrition, Federal University of Goias, Goiânia 74605-080, Brazil
3 shared publications - Gislene Batista Lima
Faculty of Nutrition, Federal University of Goias, Goiânia 74605-080, Brazil
3 shared publications - Lila Missae Oyama
Graduate Program in Nutrition, Discipline of Nutrition Physiology, Department of Physiology, Universidade Federal de São Paulo-UNIFESP, São Paulo 04023-062, Brazil
3 shared publications - Maria Aderuza Horst
Nutritional Genomics Research Group, Faculty of Nutrition Universidade Federal de Goiás (UFG) Goiânia Goiás Brazil
3 shared publications
Latest Publications
- Open Access
Curcumin Supplementation Improves Gastrointestinal Symptoms in Women with Severe Obesity: A Double-Blind, Randomized, Placebo-Controlled Trial—A Pilot Study
Gastrointestinal symptoms, including reflux, bloating, dyspepsia, stomach pain, and altered bowel patterns, are commonly reported in individuals with severe obesity and may significantly impact quality of life. Background/Objectives: Curcumin, a bioactive compound found in turmeric (Curcuma longa L.), possesses anti-inflammatory and antioxidant properties and has been investigated for its potential role in gastrointestinal health. However, its effects in individuals with severe obesity remain unclear. Methods: This double-blind, placebo-controlled clinical trial aimed to evaluate the effect of curcumin supplementation on gastrointestinal symptoms in women with severe obesity. Thirty-one women with a body mass index (BMI) ≥ 40 kg/m2 undergoing bariatric surgery were randomized to receive either 1500 mg of curcumin (98.75%) or a placebo (1500 mg corn starch) daily for 13 weeks. Gastrointestinal symptoms were assessed using the Gastrointestinal Symptom Rating Scale (GSRS), and stool consistency was assessed using the Bristol Stool Scale. Anthropometric measurements were also collected. Results: Participants had an average age of 33.1 ± 8 years and a BMI of 45.6 ± 3.31 kg/m2. No differences were observed between groups at baseline. At the end of the study, the curcumin group showed a significant reduction in the GSRS’s total score compared to the placebo group (p = 0.002), with improvements in eructation (p = 0.011) and constipation (p = 0.007). Additionally, the curcumin group showed reduced BMI (p = 0.019) and neck circumference (p = 0.042). Conclusions: These findings suggest that curcumin supplementation may alleviate some gastrointestinal symptoms and improve anthropometric measures in women with severe obesity, providing a potential dietary strategy.
Open AccessCurcumin Supplementation Improves Gastrointestinal Symptoms in Women with Severe Obesity: A Double-Blind, Randomized, Placebo-Controlled Trial—A Pilot Study
Gastrointestinal symptoms, including reflux, bloating, dyspepsia, stomach pain, and altered bowel patterns, are commonly reported in individuals with severe obesity and may significantly impact quality of life. Background/Objectives: Curcumin, a bioactive compound found in turmeric (Curcuma longa L.), possesses anti-inflammatory and antioxidant properties and has been investigated for its potential role in gastrointestinal health. However, its effects in individuals with severe obesity remain unclear. Methods: This double-blind, placebo-controlled clinical trial aimed to evaluate the effect of curcumin supplementation on gastrointestinal symptoms in women with severe obesity. Thirty-one women with a body mass index (BMI) ≥ 40 kg/m2 undergoing bariatric surgery were randomized to receive either 1500 mg of curcumin (98.75%) or a placebo (1500 mg corn starch) daily for 13 weeks. Gastrointestinal symptoms were assessed using the Gastrointestinal Symptom Rating Scale (GSRS), and stool consistency was assessed using the Bristol Stool Scale. Anthropometric measurements were also collected. Results: Participants had an average age of 33.1 ± 8 years and a BMI of 45.6 ± 3.31 kg/m2. No differences were observed between groups at baseline. At the end of the study, the curcumin group showed a significant reduction in the GSRS’s total score compared to the placebo group (p = 0.002), with improvements in eructation (p = 0.011) and constipation (p = 0.007). Additionally, the curcumin group showed reduced BMI (p = 0.019) and neck circumference (p = 0.042). Conclusions: These findings suggest that curcumin supplementation may alleviate some gastrointestinal symptoms and improve anthropometric measures in women with severe obesity, providing a potential dietary strategy.
- Open Access
Association between Serum Fatty Acids Profile and MetScore in Women with Severe Obesity
Background: Metabolic syndrome (MetS) is a set of conditions associated with an increased cardiovascular risk. Several serum fatty acids (FAs) seem to play an essential role in the development of cardiometabolic diseases and mortality. Thus, it is imperative to explore the impact of FAs on MetS parameters, using an early MetS screening tool such as MetScore, which is readily available in clinical practice. Aim: The aim of this study was to assess the potential correlation between serum FAs and cardiovascular risk using a MetScore. Methods: This cross-sectional study involved 41 women with severe obesity. The MetScore was calculated, and participants were categorized into high- and low-cardiovascular-risk groups based on the median MetScore value. Gas chromatography was used to quantify serum FAs. Generalized Linear Models were used to compare group means. The association was assessed through simple logistic regression, and an adjusted logistic regression was conducted to validate the association between Metscore and serum FAs. Results: The high-cardiovascular-risk group exhibited elevated values of HOMA-IR, palmitic, oleic, cis-vaccenic, and monounsaturated fatty acids, as well as the SCD-18C, indicating a heightened cardiovascular risk. Conversely, HDL-c, QUICK, gamma-linolenic, and eicosatetraenoic fatty acids showed lower values compared to the low-risk group. Conclusions: Women with severe obesity and high cardiovascular risk have lower values of some omega-3 and omega-6 FAs, considered cardioprotective and anti-inflammatory, and have higher lipogenic activity and FAs, correlated with high cardiovascular risk. These findings emphasize the need to address lipid metabolism in this population as a therapeutic target to reduce cardiovascular risk. Future research should explore clinical interventions that modulate fatty acid metabolism to mitigate cardiometabolic complications.
Open AccessAssociation between Serum Fatty Acids Profile and MetScore in Women with Severe Obesity
Background: Metabolic syndrome (MetS) is a set of conditions associated with an increased cardiovascular risk. Several serum fatty acids (FAs) seem to play an essential role in the development of cardiometabolic diseases and mortality. Thus, it is imperative to explore the impact of FAs on MetS parameters, using an early MetS screening tool such as MetScore, which is readily available in clinical practice. Aim: The aim of this study was to assess the potential correlation between serum FAs and cardiovascular risk using a MetScore. Methods: This cross-sectional study involved 41 women with severe obesity. The MetScore was calculated, and participants were categorized into high- and low-cardiovascular-risk groups based on the median MetScore value. Gas chromatography was used to quantify serum FAs. Generalized Linear Models were used to compare group means. The association was assessed through simple logistic regression, and an adjusted logistic regression was conducted to validate the association between Metscore and serum FAs. Results: The high-cardiovascular-risk group exhibited elevated values of HOMA-IR, palmitic, oleic, cis-vaccenic, and monounsaturated fatty acids, as well as the SCD-18C, indicating a heightened cardiovascular risk. Conversely, HDL-c, QUICK, gamma-linolenic, and eicosatetraenoic fatty acids showed lower values compared to the low-risk group. Conclusions: Women with severe obesity and high cardiovascular risk have lower values of some omega-3 and omega-6 FAs, considered cardioprotective and anti-inflammatory, and have higher lipogenic activity and FAs, correlated with high cardiovascular risk. These findings emphasize the need to address lipid metabolism in this population as a therapeutic target to reduce cardiovascular risk. Future research should explore clinical interventions that modulate fatty acid metabolism to mitigate cardiometabolic complications.
- Open Access
- 3 October 2024
- Published by MDPI AG in Biomedicines
- Vol. 12 (10) , 2248
Serum Fatty Acids and Inflammatory Patterns in Severe Obesity: A Preliminary Investigation in Women
Background: Inflammation plays a central role in many chronic diseases that characterize modern society. Leptin/adiponectin and adiponectin/leptin ratios have been recognized as notable markers of dysfunctional adipose tissue and, consequently, an inflammatory state. Methods: Blood samples were collected from 41 adult volunteers (40.2 ± 8.3 years) diagnosed with severe obesity (BMI 46.99; 42.98–51.91 kg/m2). The adipokines were quantified using an enzyme-linked immunosorbent assay, while the serum fatty acid analysis was conducted using chromatography. Results: The results unveiled a positive correlation between the leptin/adiponectin ratio and the 20:3n6 fatty acid (r = 0.52, p = 0.001), as well as a similar positive correlation between the adiponectin/leptin ratio and the 22:6n3 fatty acid (r = 0.74, p = 0.001). In the regression analysis, the 22:6n3 fatty acid predicted the adiponectin/leptin ratio (β = 0.76, p < 0.001), whereas C20:3 n-6 was a predictor for inflammatory markers (β = 4.84, p < 0.001). Conclusions: In conclusion, the 22:6n3 fatty acid was demonstrated to be a predictive factor for the adiponectin/leptin ratio and C20:3 n-6 was a predictor for inflammatory markers. This discovery, novel within this population, can help develop new intervention strategies aimed at controlling the inflammatory status in individuals classified as having severe obesity.
- 3 October 2024
- Published by MDPI AG in Biomedicines
- Vol. 12 (10) , 2248
Open AccessSerum Fatty Acids and Inflammatory Patterns in Severe Obesity: A Preliminary Investigation in Women
Background: Inflammation plays a central role in many chronic diseases that characterize modern society. Leptin/adiponectin and adiponectin/leptin ratios have been recognized as notable markers of dysfunctional adipose tissue and, consequently, an inflammatory state. Methods: Blood samples were collected from 41 adult volunteers (40.2 ± 8.3 years) diagnosed with severe obesity (BMI 46.99; 42.98–51.91 kg/m2). The adipokines were quantified using an enzyme-linked immunosorbent assay, while the serum fatty acid analysis was conducted using chromatography. Results: The results unveiled a positive correlation between the leptin/adiponectin ratio and the 20:3n6 fatty acid (r = 0.52, p = 0.001), as well as a similar positive correlation between the adiponectin/leptin ratio and the 22:6n3 fatty acid (r = 0.74, p = 0.001). In the regression analysis, the 22:6n3 fatty acid predicted the adiponectin/leptin ratio (β = 0.76, p < 0.001), whereas C20:3 n-6 was a predictor for inflammatory markers (β = 4.84, p < 0.001). Conclusions: In conclusion, the 22:6n3 fatty acid was demonstrated to be a predictive factor for the adiponectin/leptin ratio and C20:3 n-6 was a predictor for inflammatory markers. This discovery, novel within this population, can help develop new intervention strategies aimed at controlling the inflammatory status in individuals classified as having severe obesity.
- Open Access
- 31 May 2024
- Published by MDPI AG in Biomedicines
- Vol. 12 (6) , 1222
HOMA-IR as a Predictor of PAI-1 Levels in Women with Severe Obesity
Background: Obesity is a chronic inflammatory disorder that increases the risk of cardiovascular diseases (CVDs). Given the high CVD mortality rate among individuals with obesity, early screening should be considered. Plasminogen activator inhibitor (PAI-1), a cytokine that links obesity and CVDs, represents a promising biomarker. However, PAI-1 is not part of the clinical routine due to its high cost. Therefore, it is necessary to find good predictors that would allow an indirect assessment of PAI-1. Methods: This study enrolled 47 women with severe obesity (SO). The obtained anthropometric measurements included weight, height, neck (NC), waist (WC), and hip circumference (HC). Blood samples were collected to analyse glucose and lipid profiles, C-reactive protein, liver markers, adiponectin, and PAI-1 (determined by ELISA immunoassay). Homeostasis model assessment-adiponectin (HOMA-AD), homeostasis model assessment of insulin resistance (HOMA-IR), quantitative insulin sensitivity check index (QUICKI), triglyceride–glucose index (TyG), and atherogenic index of plasma (AIP) were calculated. The women were grouped according to PAI-1 levels. The data were analysed using IBM SPSS Statistics, version 21. The significance level for the analysis was set at 5%. Results: Women with SO who have higher levels of PAI-1 have lower values of high-density lipoprotein cholesterol (HDL) (p = 0.037) and QUICKI (0.020) and higher values of HOMA-AD (0.046) and HOMA-IR (0.037). HOMA-IR was demonstrated to be a good predictor of PAI-1 in this sample (B = 0.2791; p = 0.017). Conclusions: HOMA-IR could be used as a predictor of PAI-1 levels, pointing out the relevance of assessing glycaemic parameters for the prevention of CVDs in women with SO.
- 31 May 2024
- Published by MDPI AG in Biomedicines
- Vol. 12 (6) , 1222
Open AccessHOMA-IR as a Predictor of PAI-1 Levels in Women with Severe Obesity
Background: Obesity is a chronic inflammatory disorder that increases the risk of cardiovascular diseases (CVDs). Given the high CVD mortality rate among individuals with obesity, early screening should be considered. Plasminogen activator inhibitor (PAI-1), a cytokine that links obesity and CVDs, represents a promising biomarker. However, PAI-1 is not part of the clinical routine due to its high cost. Therefore, it is necessary to find good predictors that would allow an indirect assessment of PAI-1. Methods: This study enrolled 47 women with severe obesity (SO). The obtained anthropometric measurements included weight, height, neck (NC), waist (WC), and hip circumference (HC). Blood samples were collected to analyse glucose and lipid profiles, C-reactive protein, liver markers, adiponectin, and PAI-1 (determined by ELISA immunoassay). Homeostasis model assessment-adiponectin (HOMA-AD), homeostasis model assessment of insulin resistance (HOMA-IR), quantitative insulin sensitivity check index (QUICKI), triglyceride–glucose index (TyG), and atherogenic index of plasma (AIP) were calculated. The women were grouped according to PAI-1 levels. The data were analysed using IBM SPSS Statistics, version 21. The significance level for the analysis was set at 5%. Results: Women with SO who have higher levels of PAI-1 have lower values of high-density lipoprotein cholesterol (HDL) (p = 0.037) and QUICKI (0.020) and higher values of HOMA-AD (0.046) and HOMA-IR (0.037). HOMA-IR was demonstrated to be a good predictor of PAI-1 in this sample (B = 0.2791; p = 0.017). Conclusions: HOMA-IR could be used as a predictor of PAI-1 levels, pointing out the relevance of assessing glycaemic parameters for the prevention of CVDs in women with SO.
- Open Access
- 29 September 2023
- Published by Seven Events
Undergraduate monitoring: Discipline of research methodology
This study constitutes an experience report of academic monitoring activities developed in the Research Methodology discipline of the undergraduate course in Nutrition at the Federal University of Goiás (UFG). The aim is to describe the experience in voluntary monitoring of the discipline for students of the second period of the graduation course in nutrition at UFG. This report highlights the importance of monitoring as an instrument for training and academic development of the monitor, and facilitating the learning of the students. Furthermore, the monitor constitutes a link between the adviser teacher and the student, who encourages changes and adaptations aimed at improving the teaching-learning process. DOI:https://doi.org/10.56238/uniknowindevolp-123
- 29 September 2023
- Published by Seven Events
Open AccessUndergraduate monitoring: Discipline of research methodology
This study constitutes an experience report of academic monitoring activities developed in the Research Methodology discipline of the undergraduate course in Nutrition at the Federal University of Goiás (UFG). The aim is to describe the experience in voluntary monitoring of the discipline for students of the second period of the graduation course in nutrition at UFG. This report highlights the importance of monitoring as an instrument for training and academic development of the monitor, and facilitating the learning of the students. Furthermore, the monitor constitutes a link between the adviser teacher and the student, who encourages changes and adaptations aimed at improving the teaching-learning process. DOI:https://doi.org/10.56238/uniknowindevolp-123
- Open Access
- 31 July 2023
- Published by Brazilian Journals in OBSERVATÓRIO DE LA ECONOMÍA LATINOAMERICANA
- Vol. 21 (8) , 10069-10078
Metodologia da pesquisa na graduação: relato de experiência em atividade de monitoria
Este artigo constitui um relato de experiência das atividades de monitoria acadêmica desenvolvidas na disciplina de Metodologia da Pesquisa do curso de graduação em nutrição da Universidade Federal de Goiás (UFG). O objetivo do estudo é descrever a vivência em monitoria voluntária da disciplina, ofertada aos estudantes do segundo período letivo do curso de graduação em nutrição da UFG. Este relato destaca a importância da monitoria como instrumento de formação e desenvolvimento acadêmico do monitor, além de ser um elo entre professor orientador e discente, que facilita o aprendizado dos estudantes da disciplina, e amplia a participação dos discentes nas atividades de ensino e aprendizagem na universidade.
- 31 July 2023
- Published by Brazilian Journals in OBSERVATÓRIO DE LA ECONOMÍA LATINOAMERICANA
- Vol. 21 (8) , 10069-10078
Open AccessMetodologia da pesquisa na graduação: relato de experiência em atividade de monitoria
Este artigo constitui um relato de experiência das atividades de monitoria acadêmica desenvolvidas na disciplina de Metodologia da Pesquisa do curso de graduação em nutrição da Universidade Federal de Goiás (UFG). O objetivo do estudo é descrever a vivência em monitoria voluntária da disciplina, ofertada aos estudantes do segundo período letivo do curso de graduação em nutrição da UFG. Este relato destaca a importância da monitoria como instrumento de formação e desenvolvimento acadêmico do monitor, além de ser um elo entre professor orientador e discente, que facilita o aprendizado dos estudantes da disciplina, e amplia a participação dos discentes nas atividades de ensino e aprendizagem na universidade.